Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 351 results for "Ibrutinib"

Pharmacyclics submits sNDA to FDA for leukaemia drug Imbruvica
Pharmaceutical Technology

PHARMACYCLICS : Supplemental New Drug Application for IMBRUVIC...

By a News Reporter-Staff News Editor at Biotech Week -- Janssen Research & Development, LLC ("Janssen") announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration (FDA) ... 4 Traders, 1 day ago
[x]  

17 images for Ibrutinib

PR inside, 1 month ago
Cancernetwork.com, 2 months ago
Medical Marketing And Media, 2 months ago
ABC News 4 Charleston, 2 months ago
4 Traders, 2 months ago
Virtual Strategy Magazine, 2 months ago
Seeking Alpha, 2 months ago
Drug Discovery and Development, 3 months ago
Lancet Oncology, 3 months ago
MedIndia, 3 months ago

2/24/14 - The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia

By a News Reporter-Staff News Editor at Clinical Trials Week Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with chronic lymphocytic leukemia (CLL) is a significant advance for patients with this blood ...
 Pharmacy Choice1 month ago The Leukemia & Lymphoma Society Applauds FDA''s Approval of Ibrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia  Asian Hospital & Healthcare Management1 month ago FDA Sends Valentine to CLL Patients  Dermatology Online Journal1 month ago
Chemotherapy Advisor

Persistent lymphocytosis with ibrutinib does not indicate early relapse

Persistent lymphocytosis lasting more than 12 months in patients with chronic lymphocytic leukemia undergoing treatment with ibrutinib is not associated with a greater likelihood of early relapse. A prospective observational study in 85 relapsed ...
 Oncology Report2 weeks ago Marizomib Designated Orphan Drug Status for Multiple Myeloma  Chemotherapy Advisor1 month ago Erratum: Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia  New England Journal of Medicine1 month ago Imbruvica approved to block leukemia cancer cells ability to grow and divide  Examiner.com1 month ago
[x]  

1 Drug Critical to Johnson & Johnson's Future Success

The wins are coming courtesy of the cancer drug ibrutinib, a compound that's already won approval from the FDA as a treatment for both mantle cell leukemia and chronic lymphocytic leukemia. Those approvals have helped lift shares in both companies, ...
 Motley Fool1 month ago Dow Debate: Will Johnson & Johnson Crush Pfizer?  Daily Finance1 month ago

Supplemental New Drug Application Filed for Ibrutinib (Imbruvica) for Treatment of Leukemia and Lymphoma

Treatment improves survival versus ofatumumab A supplemental new drug application (sNDA) has been submitted to the FDA based on data from a phase III, open-label, head-to-head comparison of single-agent ibrutinib (Imbruvica, Pharmacyclics/Janssen ...
 P&T Community1 week ago

Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment

Primary research Xiaohui Zheng , Ning Ding , Yuqin Song , Lixia Feng and Jun Zhu Cancer Cell International 2014, 14 :32 doi:10.1186/1475-2867-14-32 Published: 3 April 2014 Abstract (provisional) Background Although rituximab in ...
 Cancer Cell International2 weeks ago Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014  Yahoo! Finance4 weeks ago
[x]  

JMP's King Recommends Shares of Pharmacyclics (Aud

Related Michael King, an analyst with JMP Group Inc. in New York, says Ibrutinib, a lymphoma drug under development by Pharmacyclics Inc. (PCYC) , is light years ahead of standard chemotherapy. King talks with Bloomberg's Tom Keene and Michael ...
 Yahoo! Singapore1 month ago King: How the Oncology Drug Development Machine Builds Biotech Wealth  Equities.com1 month ago Exuberant, Yes: Michael King on How the Oncology Drug Development Machine Builds Biotech Wealth  Jutia Group1 month ago

PHARMACYCLICS : Justification and Approval - 65-- IBRUTINIB (IMBRUVICA) PHARMACYCLICS

 4 Traders1 month ago BioClinica Technology Supports Pharmacyclics in Achieving Early Approval of IMBRUVICA and Breakthrough Therapy Designations for Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)  Fierce Biotech IT1 month ago J&J, Pharmacyclics and the future of Big Pharma dealmakingby Damian Garde  FierceBiotech1 month ago PHARMACYCLICS, INC. : BioClinica Technology Supports Pharmacyclics in Achieving Early Approval of IMBRUVICA(TM) and Breakthrough Therapy Designations for Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)  4 Traders1 month ago
[x]  

FDA Grants Accelerated Approval for Ibrutinib for CLL

Volume 23 Issue Number 2 February 2014 ISSN 1059380 The US Food and Drug Administration (FDA) on February 12, 2014 granted accelerated approval for the expanded use of ibrutinib, marketed as Imbruvica, for chronic lymphocytic leukemia (CLL) ...
 CancerWatch1 month ago

U.S. Food and Drug Administration Approves IMBRUVICA ibrutinib as a Single Agent for Patients with Chronic Lymphocytic Leukemia Who Have Received at...

U.S. Food and Drug Administration Approves IMBRUVICA ibrutinib as a Single Agent for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy By a News Reporter-Staff News Editor at Biotech Week Pharmacyclics, Inc.
 Pharmacy Choice1 month ago Pharmacyclics, Inc. : U.S. Food and Drug Administration Approves IMBRUVICA ibrutinib as a Single Agent for Patients with Chronic Lymphocytic Leukemia Who Have Received at...  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Ibrutinib
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less